Nicholas J. Gross

Nicholas J. Gross's AcademicInfluence.com Rankings

Nicholas J. Gross

Philosophy

#9159

World Rank

#12674

Historical Rank

Logic

#6149

World Rank

#7636

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Nicholas J. Gross's Degrees

PhD Pulmonology University of California, San Francisco
Doctorate Medicine University of California, San Francisco

Why Is Nicholas J. Gross Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Nicholas J. Gross's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. Department of Veterans Affairs Cooperative Study Group. (1999) (733)
Pulmonary effects of radiation therapy. (1977) (553)
Efficacy of salmeterol xinafoate in the treatment of COPD. (1999) (532)
Apparent turnover of mitochondrial deoxyribonucleic acid and mitochondrial phospholipids in the tissues of the rat. (1969) (333)
Anticholinergic, antimuscarinic bronchodilators. (2015) (269)
Role of the parasympathetic system in airway obstruction due to emphysema. (1984) (177)
Routine nebulized ipratropium and albuterol together are better than either alone in COPD. The COMBIVENT Inhalation Solution Study Group. (1997) (151)
Comparison of the anticholinergic bronchodilator ipratropium bromide with metaproterenol in chronic obstructive pulmonary disease. A 90-day multi-center study. (1986) (149)
Anticholinergic agents in asthma and COPD. (2006) (137)
Dose response to ipratropium as a nebulized solution in patients with chronic obstructive pulmonary disease. A three-center study. (1989) (125)
Cholinergic bronchomotor tone in COPD. Estimates of its amount in comparison with that in normal subjects. (1989) (123)
Allergy to laboratory animals: epidemiologic, clinical, and physiologic aspects, and a trial of cromolyn in its management. (1980) (120)
Alternative mechanisms for tiotropium. (2009) (115)
Biochemical and stereological analysis of rat liver mitochondria in different thyroid states (1978) (104)
Inhalation by Nebulization of Albuterol-Ipratropium Combination (Dey Combination) Is Superior to Either Agent Alone in the Treatment of Chronic Obstructive Pulmonary Disease (1998) (98)
CONTROL OF MITOCHONDRIAL TURNOVER UNDER THE INFLUENCE OF THYROID HORMONE (1971) (95)
Surfactant subtypes in mice: characterization and quantitation. (1989) (94)
Surfactant subtypes of mice: metabolic relationships and conversion in vitro. (1989) (92)
Efficacy and safety of once-daily aclidinium in chronic obstructive pulmonary disease (2011) (84)
Clinical InvestigationsANTITRYPSINAugmentation Therapy With α1-Antitrypsin: Patterns of Use and Adverse Events (2003) (80)
New Therapies for Asthma and Chronic Obstructive Pulmonary Disease (2017) (77)
The mode of action of anticholinergics in asthma (2018) (66)
Extrapulmonary effects of chronic obstructive pulmonary disease (2001) (64)
Consensus statement: aerosols and delivery devices. American Association for Respiratory Care. (2000) (64)
Consensus statement: aerosols and delivery devices. (2000) (64)
Effects of an anticholinergic bronchodilator on arterial blood gases of hypoxemic patients with chronic obstructive pulmonary disease. Comparison with a beta-adrenergic agent. (1987) (63)
Extracellular metabolism of pulmonary surfactant: the role of a new serine protease. (1995) (63)
Chronic obstructive pulmonary disease outcome measurements: what's important? What's useful? (2005) (63)
Protective effect of corticosteroids on radiation pneumonitis in mice. (1988) (61)
Gallium-67 scanning for carcinoma of the lung. (1976) (60)
Treatment of Chronic Obstructive Pulmonary Disease with Roflumilast, a New Phosphodiesterase 4 Inhibitor (2010) (60)
Effects of salmeterol on arterial blood gases in patients with stable chronic obstructive pulmonary disease. Comparison with albuterol and ipratropium. (1999) (57)
Replicating molecules of circular mitochondrial DNA. (1968) (54)
Serine proteinase requirement for the extra-cellular metabolism of pulmonary surfactant. (1990) (54)
Radiation pneumonitis in mice. Some effects of corticosteroids on mortality and pulmonary physiology. (1980) (54)
Impaired surfactant phospholipid metabolism in hyperoxic mouse lungs. (1981) (53)
Experimental radiation pneumonitis. IV. Leakage of circulatory proteins onto the alveolar surface. (1980) (53)
Augmentation therapy with alpha1-antitrypsin: patterns of use and adverse events. (2003) (51)
Efficacy and safety of formoterol fumarate delivered by nebulization to COPD patients. (2008) (49)
The pathogenesis of radiation-induced lung damage (2007) (49)
Synthesis of new strands of mitochondrial and nuclear deoxyribonucleic acid by semiconservative replication. (1969) (47)
The form and size of mitochondrial DNA of the red bean, Phaseolus vulgaris. (1968) (45)
Rising Costs of COPD and the Potential for Maintenance Therapy to Slow the Trend. (2014) (43)
Self-management in chronic obstructive pulmonary disease. Time for a paradigm shift? (2014) (42)
Requirements for extracellular metabolism of pulmonary surfactant: tentative identification of serine protease. (1992) (41)
Recycling of surfactant in black and beige mice: pool sizes and kinetics. (1988) (41)
Effects of some nonsteroidal anti-inflammatory agents on experimental radiation pneumonitis. (1991) (40)
Lung "surfactant convertase" is a member of the carboxylesterase family. (1997) (38)
What is this thing called love? --or, defining asthma. (2015) (37)
Alveolar macrophage number: an index of the effect of radiation on the lungs. (1977) (37)
The GOLD standard for chronic obstructive pulmonary disease. (2001) (33)
Cardiac safety profile of nebulized formoterol in adults with COPD: a 12-week, multicenter, randomized, double- blind, double-dummy, placebo- and active-controlled trial. (2007) (33)
Clinical Significance of Splinter Haemorrhages (1963) (31)
Chronic obstructive pulmonary disease. Current concepts and therapeutic approaches. (1990) (29)
The constant size of circular mitochondrial DNA in several organisms and different organs. (1967) (27)
Surfactant subtypes in experimental lung damage: radiation pneumonitis. (1991) (27)
Safety and tolerability of inhaled loxapine in subjects with asthma and chronic obstructive pulmonary disease--two randomized controlled trials. (2014) (25)
Separation of alveolar surfactant into subtypes. A comparison of methods. (2000) (24)
Comparative cost-effectiveness analysis of theophylline and ipratropium bromide in chronic obstructive pulmonary disease. A three-center study. (1993) (24)
Novel antiinflammatory therapies for COPD. (2012) (23)
Outcome Measures for COPD Treatments: A Critical Evaluation (2004) (22)
Functional, biochemical, and morphologic changes in alveolar macrophages following thoracic x-irradiation. (1978) (22)
Monitoring of immunologic status of patients receiving BCG therapy for malignant disease (1976) (20)
Correlation Between the Physical Signs of Hypercapnia and the Mixed Venous Pco2 (1963) (20)
HEAT DENATURATION STUDIES OF RAT LIVER MITOCHONDRIAL DNA (1972) (20)
Oxitropium bromide, a new anticholinergic bronchodilator. (1986) (19)
Molecular cloning, characterization, and differential expression pattern of mouse lung surfactant convertase. (1998) (19)
Dose Response to Ipratropium as a Nebulized Solution in Patients with Chronic Obstructive Pulmonary Disease: Reply (1989) (18)
Unusual Neurological and Cardiovascular Complications of Respiratory Failure (1963) (18)
Safety and tolerability of inhalational anticholinergics in COPD (2013) (17)
Inhibition of surfactant subtype convertase in radiation model of adult respiratory distress syndrome. (1991) (17)
Human skin responses to products of concanavalin A-activated lymphocytes. (1973) (17)
Mechanical properties of mouse lungs: effects of degassing on normal, hyperoxic, and irradiated lungs. (1981) (15)
A short tour around the muscarinic receptor. (1988) (15)
Methylprednisolone increases the toxicity of oxygen in adult mice. Mechanical and biochemical effects on the surfactant system. (1984) (15)
The lung health study. Disappointment and triumph. (1994) (15)
Replicative activity of lung type 2 cells following lung X irradiation. (1987) (14)
COPD: a disease of reversible air-flow obstruction. (1986) (14)
Effects of radiation on the lung (1996) (13)
The COPD Pipeline (2009) (13)
Airway inflammation in COPD. Reality or myth? (1995) (13)
The role of alpha 1-antitrypsin in the control of extracellular surfactant metabolism. (1995) (13)
Thymidine content and turnover in the rat. (1968) (13)
Nebulized formoterol fumarate: Dose selection and pharmacokinetics. (2008) (12)
Outcome measurements in COPD: are we schizophrenic? (2003) (12)
Primary care of the patient with chronic obstructive pulmonary disease-part 2: pharmacologic treatment across all stages of disease. (2008) (12)
Influence of Phospholipid Composition on the Properties of Reconstituted Surfactants (1999) (12)
Inhaled glycopyrrolate for the treatment of chronic obstructive pulmonary disease (2018) (11)
Experimental radiation pneumonitis. Corticosteroids increase the replicative activity of alveolar type 2 cells. (1988) (11)
Chronic Obstructive Pulmonary Disease Outcome Measurements (2012) (11)
The influence of anticholinergic agents on treatment for bronchitis and emphysema. (1991) (10)
Protein-lipid interactions and enzyme requirements for light subtype generation on cycling reconstituted surfactant. (1998) (10)
Anticholinergic agents in COPD. (1987) (10)
Nebulized formoterol: a review of clinical efficacy and safety in COPD (2010) (10)
Early physiologic and biochemical effects of thoracic X-irradiation on the pulmonary surfactant system. (1978) (10)
Surfactant convertase action is not essential for surfactant film formation. (1997) (9)
Responses to steroids and bronchodilators in COPD in the ISOLDE trial: the fat lady sings on (2003) (9)
Efficacy and Safety of the Novel, Long-Acting Antimuscarinic, Aclidinium Bromide, in COPD Patients in a Phase III Study: ACCLAIM/COPD II. (2009) (8)
Diagnosis of sarcoidosis by labial gland biopsy. (1972) (7)
Experimental radiation pneumonitis: changes in physiology of the alveolar surface. (1978) (7)
Bronchial brush biopsy in Hodgkin's disease. (1974) (7)
Pulmonary surfactant: unanswered questions. (1995) (6)
Experimental radiation pneumonitis. III. Phospholipid studies on the lungs. (1979) (6)
Heart denaturation studies of rat liver mitrochondrial DNA. A denaturation map and changes in molecular configurations. (1972) (6)
MASSIVE OVERDOSE OF ATROPINE METHONITRATE WITH ONLY SLIGHT UNTOWARD EFFECTS (1985) (5)
Patterns of Use and Adverse Events (2015) (5)
Chronic obstructive pulmonary disease: an evidence-based approach to treatment with a focus on anticholinergic bronchodilation. (2008) (4)
Absence of tachyphylaxis to inhaled atropine in patients with chronic obstructive pulmonary disease. (1989) (4)
The use of anticholinergic agents in the treatment of airways disease. (1988) (4)
The COPD Pipeline VII (2010) (4)
The COPD Pipeline X (2011) (4)
Is dipalmitoylphosphatidylcholine a substrate for convertase? (2000) (3)
Surfactant convertase action is not essential for surfactant film formation. (1997) (3)
Anticholinergic agents in chronic bronchitis and emphysema. (1987) (3)
Molecular cloning, characterization, and differential expression pattern of mouse lung surfactant convertase. (1998) (3)
The COPD Pipeline XI (2011) (3)
The paradoxical skin response in sarcoidosis. A hypothesis. (1973) (3)
Albuterol inhalers. (2007) (3)
Chronic obstructive pulmonary disease: the treatment (Part One) (2006) (3)
Phytohemagglutinin activation of lymphocytes: quantitative comparison of different preparations. (1978) (3)
Bronchial asthma; current immunologic, pathophysiologic, and management concepts (1974) (3)
Management of chronic obstructive pulmonary disease. (1996) (2)
Immune status in lung cancer: effects of BCG immunotherapy. (1976) (2)
Training of Physicians in the N.H.S (1971) (2)
The COPD Pipeline, 2004-2014. (2014) (2)
The COPD Pipeline, XXVIII. (2015) (2)
Cell-mediated immunity in sarcoidosis: effect of corticosteroids. (1977) (2)
CARDIOVASCULAR SAFETY OF NEBULIZED FORMOTEROL IN COPD PATIENTS: A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY (2007) (2)
The COPD Pipeline IX (2011) (2)
The COPD Pipeline V (2010) (2)
The COPD Pipeline XVII (2012) (1)
The Paradoxical Skin Response in Sarcoidosis (2015) (1)
Nebulized Long-Acting Beta2-Agonists: More Than Just Bridging Gaps in the Management of Symptomatic COPD. (2017) (1)
The COPD Pipeline, XXV. (2014) (1)
Augmentation therapy with alpha1-antitrypsin: patterns of use and adverse events. 2003. (2009) (1)
Characterization of Safety With Roflumilast, an Oral Phosphodiesterase-4 Inhibitor for the Treatment of COPD (2010) (1)
The COPD Pipeline (2009) (1)
The COPD Pipeline IV (2010) (1)
ANTICHOLINERGIC AGENTS AS BRONCHODILATORS (1999) (1)
The COPD Pipeline XXXIX. (2018) (1)
The International Clinical Respiratory Group. Report of the first meeting. (1991) (1)
The COPD Pipeline XXXVI. (2017) (1)
The COPD Pipeline XXXIII. (2017) (1)
The COPD Pipeline XXVII. (2015) (1)
The COPD Pipeline XVIII (2012) (1)
The COPD Pipeline XXX. (2015) (1)
The COPD Pipeline XXIV (2013) (1)
Th1165a: a new adrenergic bronchodilator. (1978) (0)
Assessment of therapeutic benefit in asthmatic patients. The International Clinical Respiratory Group. (1993) (0)
Self-assessment of current knowledge in pulmonary diseases;: 1,206 multiple choice questions and referenced answers, (1973) (0)
Critical Care Medicine: Principles of Diagnosis and Management (1996) (0)
The COPD Pipeline XXXX. (2019) (0)
How much did biases in the study of chronic obstructive pulmonary disease medications and mortality affect the outcome? (2009) (0)
The COPD Pipeline XIII (2011) (0)
The COPD Pipeline VI (2010) (0)
Letter: Is tuberculosis preventable? (1974) (0)
Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation The COPD Pipeline XXVII (2015) (0)
The COPD Pipeline XXXII. (2016) (0)
The COPD Pipeline XX (2013) (0)
Sch 1000: A New Anticholinergic Bronchodilator1–3 (2015) (0)
Ipratropium bromide (2021) (0)
The COPD Pipeline XXII (2013) (0)
The COPD Pipeline XVI (2012) (0)
Chronic Obstructive Pulmonary Disease : An Evidence-Based Approach to Treatment With a Focus on Anticholinergic Bronchodilation REV (2008) (0)
Oxygen Administration in Respiratory Acidosis (1962) (0)
The COPD Pipeline XXI (2013) (0)
The COPD Pipeline XIX (2012) (0)
The COPD Pipeline XXXVII. (2018) (0)
In Reply: Is Tuberculosis Preventable? (1974) (0)
The COPD Pipeline XXIII (2013) (0)
Managing Acute Exacerbations of COPD: A Scorecard (2010) (0)
Surfactant phospholipid recycling in black and beige mice: kinetics (1986) (0)
Nebulized Formoterol Provides Consistent Benefits In Lung Function Across Clinical Studies (2010) (0)
The COPD Pipeline XV (2012) (0)
37 – Anticholinergic Bronchodilators (1998) (0)
The COPD Pipeline XXIX. (2015) (0)
The COPD Pipeline XIV (2012) (0)
List of contributors vii Preface xi Part I Asthma and COPD 1 Pathology of asthma and COPD : 3 inflammation and structure (2003) (0)
The COPD Pipeline XXXVIII. (2018) (0)
The COPD Pipeline VIII (2011) (0)
The COPD Pipeline XXXV. (2017) (0)
BRONCHODILATORS | Anticholinergic Agents (2006) (0)
The COPD Pipeline XII (2011) (0)
Lung cancer: An immunologic viewpoint and the prospects for immunotherapy. (1976) (0)
The COPD Pipeline, XXVI. (2015) (0)
Genetic Cripples (1971) (0)
Extracellular Metabolism of Surfactant: The Role of a Newly Identifed Serine Protease (1994) (0)
Chapter 50 – Anticholinergic Bronchodilators (2002) (0)
New inhaled anticholinergics (2012) (0)
The COPD Pipeline XXXI. (2016) (0)
The COPD Pipeline XXXIV. (2017) (0)
Drugs for the Treatment of Respiratory Diseases: Anticholinergic bronchodilators (2003) (0)
The COPD Pipeline II (2011) (0)
Inflammation oftheairways hasbeenregarded as acardinal pathophysiologic feature ofasthma for (2017) (0)
Combination Therapy with Sildenafil and Sitaxentan for Pulmonary Arterial Hypertension. (2009) (0)

This paper list is powered by the following services:

Nicholas J. Gross's Academic­Influence.com Rankings

Nicholas J. Gross's Degrees

Why Is Nicholas J. Gross Influential?

Nicholas J. Gross's Published Works

Published Works

Nicholas J. Gross's AcademicInfluence.com Rankings